Open

Coming up

Don't miss

Replay


LATEST SHOWS

AFRICA NEWS

2014-07-11 21:47 AFRICA NEWS

Read more

MEDIAWATCH

Finally, a good use for new app "Yo"

Read more

THE WORLD THIS WEEK

The World This Week - 11 July 2014 (part 2)

Read more

THE WORLD THIS WEEK

The World This Week - 11 July 2014

Read more

REPORTERS

Exclusive: an unlikely victim of the 'War on Terror'

Read more

#THE 51%

Sweden: A Feminist's Paradise?

Read more

FRANCE IN FOCUS

Politics: parties under pressure

Read more

FOCUS

In Burma, the rise of radical Buddhism

Read more

ENCORE!

Haute Couture: the hand-stitched clothing made in Paris that sells for the price of small yachts

Read more

  • Amazon snubs French free delivery ban with one-cent charge

    Read more

  • Exclusive: an unlikely victim of the 'War on Terror'

    Read more

  • Netanyahu resists international pressure to stop air strikes on Gaza

    Read more

  • The third-place playoff: the World Cup game no one wants to play

    Read more

  • Suspect in Brussels Jewish Museum shooting drops extradition appeal

    Read more

  • Kurdish forces take over two oilfields in northern Iraq

    Read more

  • Are French high school students getting smarter?

    Read more

  • Italy’s Trentin wins seventh stage of Tour de France

    Read more

  • Disgraced Suarez leaves Liverpool for Barcelona

    Read more

  • In pictures: Chanel, Dior and so much more at the Paris couture shows

    Read more

  • French ‘Civic Service’ eyes massive expansion amid huge demand

    Read more

  • In Pictures: Petrol station hit by Hamas rockets

    Read more

  • Manhunt as FIFA partner flees Rio hotel to avoid arrest

    Read more

  • Video: Palestinians fear full Israeli military offensive in Gaza

    Read more

  • Ukrainian forces close in on Donetsk

    Read more

New hope for a cure for liver cirrhosis

©

Latest update : 2008-04-01

Scientists in Japan have designed artificial molecules that when used with rats successfully reversed liver cirrhosis, a serious chronic disease in humans that until now can only be cured by transplants.

Cirrhosis is the hardening or scarring of the liver, and is caused by factors such as heavy drinking and Hepatitis B and C. The disease is especially serious in parts of Asia, including China.

 

Cirrhosis occurs when a class of liver cells starts producing collagen, a fibrous material that toughens skin and tendons. Such damage cannot be reversed although steps can be taken to prevent further damage. In advanced cases, transplants are the only way out.

 

In the journal Nature Biotechnology, the researchers said they designed molecules that can block collagen production by liver "stellate cells", which are also known to absorb vitamin A.

 

The scientists then loaded the molecules into carriers that were coated with vitamin A, which tricked the stellate cells into absorbing the molecules.

 

"By packaging the (molecules) in carriers coated with vitamin A, they tricked the stellate cells into letting in the inhibitor, which shut down collagen secretion," the researchers wrote.

 

In the study, the researchers induced liver cirrhosis in rats and then injected them with the vitamin A-laced molecules.

 

"We were able to completely eradicate the fibrosis by injecting this agent ... we cured them of the cirrhosis," Yoshiro Niitsu at the Sapporo Medical University School of Medicine in Japan said in a telephone interview.

 

"The liver is such an important organ, after you remove the fibrosis, the liver by itself starts to regenerate tissues. So liver damage is reversible."

 

Explaining how the damage reversal came about, Niitsu said: "Liver is itself responsible for the production and deposition of collagen, it also secretes certain enzymes that dissolve collagen ... dissolve the fibrosis which has already been deposited in the tissues."

 

Niitsu was hopeful that the molecules would provide a cure for cirrhosis patients in time.

 

"We hope it (a drug) will be ready for humans in a few years," he said.
 

Date created : 2008-03-31

Comments

COMMENT(S)